[1]
|
Zhou, B., Lu, Y., Hajifathalian, K., et al. (2016) Worldwide Trends in Diabetes Since 1980: A Pooled Analysis of 751 Population-Based Studies with 4•4 Million Participants. The Lancet, 387, 1513-1530.
https://doi.org/10.1016/S0140-6736(16)00618-8
|
[2]
|
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017) Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet, 390, 1211-1259.
https://doi.org/10.1016/S0140-6736(17)32154-2
|
[3]
|
Lovic, D., Piperidou, A., Zografou, I., et al. (2020) The Growing Epidemic of Diabetes Mellitus. Current Vascular Pharmacology, 18, 104-109. https://doi.org/10.2174/1570161117666190405165911
|
[4]
|
杨文英. 中国糖尿病的流行特点及变化趋势[J]. 中国科学: 生命科学, 2018, 48(8): 812-819.
|
[5]
|
Rawshani, A., Rawshani, A. and Gudbjörnsdottir, S. (2017) Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. The New England Journal of Medicine, 377, 300-301. https://doi.org/10.1056/NEJMc1706292
|
[6]
|
March, C.A., Libman, I.M., Becker, D.J., et al. (2022) From Antiq-uity to Modern Times: A History of Diabetes Mellitus and Its Treatments. Hormone Research in Paediatrics, 95, 593-607. https://doi.org/10.1159/000526441
|
[7]
|
余学锋. 胰岛素的过去、现在和未来——胰岛素制剂发展与应用[J]. 中国医学前沿杂志(电子版), 2021, 13(6): 4-8.
|
[8]
|
Pickup, J.C., Keen, H., Parsons, J.A., et al. (1978) Con-tinuous Subcutaneous Insulin Infusion: An Approach to Achieving Normoglycaemia. British Medical Journal, 1, 204-207. https://doi.org/10.1136/bmj.1.6107.204
|
[9]
|
Nimri, R., Nir, J. and Phillip, M. (2020) Insulin Pump Therapy. American Journal of Therapeutics, 27, e30-e41.
https://doi.org/10.1097/MJT.0000000000001097
|
[10]
|
National Institute for Health and Care Excellence: Guidelines (2015) Type 2 Diabetes in Adults: Management. National Institute for Health and Care Excellence (NICE), Lon-don.
|
[11]
|
Haastrup, M.B., Henriksen, J.E., Mortz, C.G., et al. (2018) Insulin Allergy Can Be Successfully Managed by a Systematic Approach. Clinical and Translational Allergy, 8, Article No. 35.
https://doi.org/10.1186/s13601-018-0223-x
|
[12]
|
Richardson, T. and Kerr, D. (2003) Skin-Related Complications of Insulin Therapy: Epidemiology and Emerging Management Strategies. American Journal of Clinical Dermatology, 4, 661-667.
https://doi.org/10.2165/00128071-200304100-00001
|
[13]
|
Aberumand, B. and Jeimy, S. (2021) The Complexities of Insulin Allergy: A Case and Approach. Allergy, Asthma & Clinical Immunology, 17, Article No. 79. https://doi.org/10.1186/s13223-021-00554-1
|
[14]
|
Ghazavi, M.K. and Johnston, G.A. (2011) Insulin Allergy. Clin-ics in Dermatology, 29, 300-305.
https://doi.org/10.1016/j.clindermatol.2010.11.009
|
[15]
|
Baur, X., Bossert, J. and Koops, F. (2003) IgE-Mediated Allergy to Recombinant Human Insulin in a Diabetic. Allergy, 58, 676-678. https://doi.org/10.1034/j.1398-9995.2003.00128.x
|
[16]
|
Nagy, E., Komlósi, Z.I., Márton, D.F., et al. (2020) Inzulin-túlérzékenységi reakció vagy valami más? Tanulságok egy eset kapcsán. Orvosi Hetilap, 161, 1483-1487. https://doi.org/10.1556/650.2020.31900
|
[17]
|
Kim, D. and Baraniuk, J. (2007) Delayed-Type Hypersensitivity Re-action to the Meta-Cresol Component of Insulin. Annals of Allergy, Asthma & Immunology, 99, 194-195. https://doi.org/10.1016/S1081-1206(10)60645-X
|
[18]
|
Porsche, R. and Brenner, Z.R. (1999) Allergy to Protamine Sulfate. Heart Lung, 28, 418-428.
https://doi.org/10.1016/S0147-9563(99)70031-2
|
[19]
|
Roest, M.A., Shaw, S. and Orton, D.I. (2003) Insu-lin-Injection-Site Reactions Associated with Type I Latex Allergy. The New England Journal of Medicine, 348, 265-266. https://doi.org/10.1056/NEJM200301163480320
|
[20]
|
袁晓勇, 高莹, 张俊清, 等. 14例胰岛素类似物过敏的病例报道及文献复习[J]. 中国糖尿病杂志, 2015, 23(9): 832-835.
|
[21]
|
Heinzerling, L. (2013) Insulin Allergy. Diabetic Medicine, 30, 891-892. https://doi.org/10.1111/dme.12233
|
[22]
|
Akinci, B., Yener, S., Bayraktar, F., et al. (2010) Allergic Reactions to Human Insulin: A Review of Current Knowledge and Treatment Options. Endocrine, 37, 33-39. https://doi.org/10.1007/s12020-009-9256-1
|
[23]
|
Heinzerling, L., Raile, K., Rochlitz, H., et al. (2008) Insulin Al-lergy: Clinical Manifestations and Management Strategies. Allergy, 63, 148-155. https://doi.org/10.1111/j.1398-9995.2007.01567.x
|
[24]
|
Jacquier, J., Chik, C.L. and Senior, P.A. (2013) A Practical, Clinical Approach to the Assessment and Management of Suspected Insulin Allergy. Diabetic Medicine, 30, 977-985. https://doi.org/10.1111/dme.12194
|
[25]
|
程庆丰, 张素华, 任伟, 等. 胰岛素泵脱敏治疗多种胰岛素制剂过敏患者1例[J]. 中国糖尿病杂志, 2010, 18(11): 876-877.
|
[26]
|
Léonet, J., Malaise, J., Goffin, E., et al. (2006) Solitary Pancreas Transplantation for Life-Threatening Allergy to Human Insulin. Transplant International, 19, 474-477. https://doi.org/10.1111/j.1432-2277.2006.00282.x
|
[27]
|
Yong, P.F., Malik, R., Arif, S., et al. (2009) Rituximab and Omalizumab in Severe, Refractory Insulin Allergy. The New England Journal of Medicine, 360, 1045-1047. https://doi.org/10.1056/NEJMc0808282
|
[28]
|
Radermecker, R.P. and Scheen, A.J. (2007) Allergy Reactions to In-sulin: Effects of Continuous Subcutaneous Insulin Infusion and Insulin Analogues. Diabetes/Metabolism Research and Reviews, 23, 348-355.
https://doi.org/10.1002/dmrr.714
|
[29]
|
Krishna, M.T. and Huissoon, A.P. (2011) Clinical Immunology Review Se-ries: An Approach to Desensitization. Clinical & Experimental Immunology, 163, 131-146. https://doi.org/10.1111/j.1365-2249.2010.04296.x
|
[30]
|
Yuan, T., Zhao, W., Wang, L., et al. (2016) Continuous Subcutaneous Insulin Infusion as an Effective Method of Desensitization Therapy for Diabetic Patients with Insulin Al-lergy: A 4-Year Single-Center Experience. Clinical Therapeutics, 38, 2489-2494.e2481. https://doi.org/10.1016/j.clinthera.2016.09.018
|
[31]
|
李理总, 陶依然, 宋荣景, 等. 胰岛素过敏患者脱敏治疗文献分析[J]. 临床药物治疗杂志, 2021, 19(5): 26-31.
|